Two new treatment regimens for Helicobacter pylori eradication: a randomised study. (Q43850638)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Two new treatment regimens for Helicobacter pylori eradication: a randomised study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Angelo Zullo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

V De Francesco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Hassan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D Faleo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Panella

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Morini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

676-679

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Relationship between antral lymphocyte density and basal gastrin levels in patients with Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Helicobacter pylori infection and gastric lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Finding the optimum treatment for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

"Cervia Working Group Report": guidelines on the diagnosis and treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Re-treatment after Helicobacter pylori eradication failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

The management of failed dual or triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

A new highly effective short-term therapy schedule for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

High Helicobacter pylori numbers are associated with low eradication rate after triple therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980044-X

7 January 2021

10.1016/S1590-8658(01)80044-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785713%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference